非布索坦要用多久？

How long should I take (Febuxostat)? Febuxostat (Febuxostat) was started at 10 mg/day for 2 weeks, then increased to 20 mg/day for 4 weeks, then to 40 mg/day. Starting with a low dose and gradually increasing the dose can prevent acute gout attacks caused by initial changes in blood uric acid levels. Treat with febuxostat (Febuxostat) 40 mg/day for 6 months, and review uric acid levels regularly. Generally, it takes 6 months to clean up excess blood uric acid in the body.

After 6 months of treatment: (1) If the blood uric acid level remains between 240 umol/l and 360 umol/l, maintain febuxostat (febuxostat) 40 mg/day treatment. (2) If the blood uric acid level is higher than 360 umol/l, increase the dose of Febuxostat (Febuxostat) by 60 mg/day, up to a maximum of 80 mg/day, and monitor blood uric acid, liver and kidney function regularly. (3) If the blood uric acid level is lower than 240 umol/l, the dose of Febuxostat (Febuxostat) can be reduced to 20 mg/day and the treatment can be maintained for 6 months. Febuxostat can be taken before, after or with meals without affecting the efficacy of the drug; the type of food will not affect the efficacy of Febuxostat. Gout patients can even take Febuxostat (Febuxostat) with milk. But this does not mean that gout patients can relax their control on a high-purine diet after taking febuxostat.

Febuxostat (Febuxostat) is used to treat chronic hyperuricemia (gout). Gout occurs because the body produces excessive blood uric acid and the kidneys' reduced ability to eliminate it. Blood uric acid accumulates in the body, causing urate crystals to accumulate in joints and internal organs.

According to officially released clinical trial data, the effective rate of Febuxostat (Febuxostat) in the general population is about 70%, which is much higher than that of allopurinol. Moreover, there is a clear difference between Febuxostat (Febuxostat) and placebo. Febuxostat is safer. Clinical trial data on more than 3,000 people show that after taking Febuxostat (Febuxostat) for six months, patients can effectively reduce uric acid in the blood to 360 μmol/L. It can be seen that the therapeutic effect of (febuxostat) is still very significant.

Related hot article recommendations: